Acinetobacter is a complex genus, and historically, there has been confusion about the
existence of multiple species. The species commonly cause nosocomial infections …

Colistin, also referred to as polymyxin E, is an effective antibiotic against most multidrug-
resistant Gram-negative bacteria and is currently used as a last-line drug for treating severe …

We identified a novel plasmid-mediated colistin-resistance gene in porcine and bovine
colistin-resistant Escherichia coli that did not contain mcr-1. The gene, termed mcr-2, a 1,617 …

Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide
spectrum of nosocomial infections. Colistin was considered a last-resort antibiotic for the …

Acinetobacter baumannii is a cause of healthcare-associated infections. Although A.
baumannii is an opportunistic pathogen, its infections are notoriously difficult to treat due to …

With regard to their structures and functions, antimicrobial agents represent a highly diverse
group of low‐molecular‐weight substances which interfere with bacterial growth, resulting in …

Acinetobacter baumannii causes nosocomial infections due to its multidrug resistance and
high environmental adaptability. Colistin is a polypeptide antibacterial agent that targets …

Colistin, which targets lipopolysaccharide (LPS), is used as a last-resort drug against severe
infections caused by drug-resistant Acinetobacter baumannii. However, A. baumannii …

Background Multi-drug resistant bacteria are a phenomenon which is on the increase
around the world, particularly with the emergence of colistin-resistant Enterobacteriaceae …

Acinetobacter baumannii, classified as priority number one by the World Health
Organization (WHO), is an opportunistic pathogen responsible for infection and is able to …